• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于脂质体的抗菌药物递送:对抗细菌感染的一种新兴方法。

Liposome-Based Antibacterial Delivery: An Emergent Approach to Combat Bacterial Infections.

作者信息

Ghosh Rita, De Mrinmoy

机构信息

Department of Organic Chemistry, Indian Institute of Science, Bangalore 560012, Karnataka, India.

出版信息

ACS Omega. 2023 Sep 22;8(39):35442-35451. doi: 10.1021/acsomega.3c04893. eCollection 2023 Oct 3.

DOI:10.1021/acsomega.3c04893
PMID:37810644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10551917/
Abstract

The continued emergence and spread of drug-resistant pathogens and the decline in the approval of new antimicrobial drugs pose a major threat to managing infectious diseases, resulting in high morbidity and mortality. Even though a significant variety of antibiotics can effectively cure many bacterial infectious diseases, microbial infections remain one of the biggest global health problems, which may be due to the traditional drug delivery system's shortcomings which lead to poor therapeutic index, low drug absorption, and numerous other drawbacks. Further, the use of traditional antibiotics to treat infectious diseases has always been accompanied by the emergence of multidrug resistance and adverse side effects. Despite developing numerous new antibiotics, nanomaterials, and various techniques to combat infectious diseases, they have persisted as major global health issues. Improving the current antibiotic delivery systems is a promising approach to solving many life-threatening infections. In this context, nanoliposomal systems have recently attracted much attention. Herein, we attempt to provide a concise summary of recent studies that have used liposomal nanoparticles as delivery systems for antibacterial medicines. The minireview also highlights the enormous potential of liposomal nanoparticles as antibiotic delivery systems. The future of these promising approaches lies in developing more efficient delivery systems by precisely targeting bacterial cells with antibiotics with minimum cytotoxicity and high bacterial combating efficacy.

摘要

耐药病原体的持续出现和传播以及新型抗菌药物获批数量的减少,对传染病的管理构成了重大威胁,导致高发病率和高死亡率。尽管种类繁多的抗生素能够有效治愈许多细菌感染性疾病,但微生物感染仍然是全球最大的健康问题之一,这可能是由于传统给药系统存在缺陷,导致治疗指数不佳、药物吸收低以及许多其他缺点。此外,使用传统抗生素治疗传染病一直伴随着多重耐药性和副作用的出现。尽管已经开发出许多新型抗生素、纳米材料和各种对抗传染病的技术,但这些问题仍然是全球主要的健康问题。改进当前的抗生素给药系统是解决许多危及生命的感染的一种有前景的方法。在这种背景下,纳米脂质体系统最近受到了广泛关注。在此,我们试图简要总结最近使用脂质体纳米颗粒作为抗菌药物递送系统的研究。这篇综述还强调了脂质体纳米颗粒作为抗生素递送系统的巨大潜力。这些有前景的方法的未来在于开发更高效的递送系统,通过以最小的细胞毒性和高抗菌效力精确地将抗生素靶向细菌细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcf/10551917/1f4bea6fb95a/ao3c04893_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcf/10551917/30df351dd0b6/ao3c04893_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcf/10551917/51e31ce81954/ao3c04893_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcf/10551917/266408685109/ao3c04893_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcf/10551917/1f4bea6fb95a/ao3c04893_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcf/10551917/30df351dd0b6/ao3c04893_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcf/10551917/51e31ce81954/ao3c04893_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcf/10551917/266408685109/ao3c04893_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edcf/10551917/1f4bea6fb95a/ao3c04893_0004.jpg

相似文献

1
Liposome-Based Antibacterial Delivery: An Emergent Approach to Combat Bacterial Infections.基于脂质体的抗菌药物递送:对抗细菌感染的一种新兴方法。
ACS Omega. 2023 Sep 22;8(39):35442-35451. doi: 10.1021/acsomega.3c04893. eCollection 2023 Oct 3.
2
Nanoliposome-based antibacterial drug delivery.基于纳米脂质体的抗菌药物递送。
Drug Deliv. 2015;22(5):581-9. doi: 10.3109/10717544.2013.863409. Epub 2013 Dec 9.
3
Tuberculosis结核病
4
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
5
Focused Insights into Liposomal Nanotherapeutics for Antimicrobial Treatment.脂质体纳米疗法用于抗菌治疗的深入见解。
Curr Med Chem. 2024 Oct 17. doi: 10.2174/0109298673322058241003073312.
6
Revolutionizing Antibacterial Strategies: Lipid Nanoparticles as Game-Changers in Combatting Multi-Drug-Resistant Infections.变革抗菌策略:脂质纳米颗粒成为对抗多重耐药感染的关键因素
Curr Med Chem. 2024 Jul 15. doi: 10.2174/0109298673314366240712105637.
7
Thymol-Decorated Gold Nanoparticles for Curing Clinical Infections Caused by Bacteria Resistant to Last-Resort Antibiotics.百里香酚修饰的金纳米颗粒治愈对抗生素耐药的临床细菌感染。
mSphere. 2023 Jun 22;8(3):e0054922. doi: 10.1128/msphere.00549-22. Epub 2023 Apr 5.
8
Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them.细菌耐药机制的突破及其应对的潜在方法。
Microb Pathog. 2016 Jun;95:32-42. doi: 10.1016/j.micpath.2016.02.009. Epub 2016 Feb 18.
9
Nanomaterials for alternative antibacterial therapy.用于替代抗菌疗法的纳米材料。
Int J Nanomedicine. 2017 Nov 10;12:8211-8225. doi: 10.2147/IJN.S132163. eCollection 2017.
10
Endocytosis-mediated redistribution of antibiotics targets intracellular bacteria.内吞作用介导的抗生素重分布靶向细胞内细菌。
Nanoscale. 2023 Mar 9;15(10):4781-4794. doi: 10.1039/d2nr05421c.

引用本文的文献

1
Green nanoscience for healthcare: Advancing biomedical innovation through eco-synthesized nanoparticle.用于医疗保健的绿色纳米科学:通过生态合成纳米颗粒推动生物医学创新。
Biotechnol Rep (Amst). 2025 Aug 12;47:e00913. doi: 10.1016/j.btre.2025.e00913. eCollection 2025 Sep.
2
Inhalable nanoparticle-based delivery systems for the treatment of pulmonary infections: and barrier-overcoming strategies.用于治疗肺部感染的基于可吸入纳米颗粒的递送系统及克服屏障的策略。
Drug Deliv. 2025 Dec;32(1):2544683. doi: 10.1080/10717544.2025.2544683. Epub 2025 Aug 11.
3
Liposome-Encapsulated Antibiotics for the Therapy of Mycobacterial Infections.

本文引用的文献

1
Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives.纳米技术作为对抗多重耐药细菌的一种有前景的方法:综述与未来展望
Biomedicines. 2023 Jan 31;11(2):413. doi: 10.3390/biomedicines11020413.
2
Effect of Biosynthesized Silver Nanoparticles on Bacterial Biofilm Changes in and .生物合成银纳米颗粒对[具体研究对象1]和[具体研究对象2]中细菌生物膜变化的影响。
Nanomaterials (Basel). 2022 Jun 25;12(13):2183. doi: 10.3390/nano12132183.
3
Gram-selective antibacterial activity of mixed-charge 2D-MoS.
用于治疗分枝杆菌感染的脂质体包封抗生素
Antibiotics (Basel). 2025 Jul 20;14(7):728. doi: 10.3390/antibiotics14070728.
4
Mucosomes as next-generation drug carriers for treating mucus-resident bacterial infections and biofilms.黏液小体作为用于治疗驻留于黏液中的细菌感染和生物膜的下一代药物载体。
Sci Rep. 2025 Jul 25;15(1):27071. doi: 10.1038/s41598-025-10496-y.
5
Dual Antibiotic-Infused Liposomes to Control Methicillin-Resistant .双重抗生素负载脂质体用于控制耐甲氧西林……
Medicines (Basel). 2025 May 22;12(2):14. doi: 10.3390/medicines12020014.
6
Design of Antimicrobial Peptides against Carbapenem-Resistant Infections with Enhanced Activity by Nanoformulation.通过纳米制剂设计具有增强活性的抗碳青霉烯类耐药感染抗菌肽
ACS Appl Bio Mater. 2025 Jul 21;8(7):6121-6131. doi: 10.1021/acsabm.5c00679. Epub 2025 Jun 24.
7
Applications of bacteriophages in precision engineering of the human gut microbiome.噬菌体在人类肠道微生物组精准工程中的应用。
Eng Microbiol. 2025 Jan 6;5(1):100189. doi: 10.1016/j.engmic.2025.100189. eCollection 2025 Mar.
8
Lipid-based nanocarriers for enhanced gentamicin delivery: a comparative study of liquid crystal nanoparticles and liposomes against Escherichia coli biofilms.用于增强庆大霉素递送的脂质纳米载体:液晶纳米颗粒和脂质体对大肠杆菌生物膜的比较研究
Drug Deliv Transl Res. 2025 Jun 12. doi: 10.1007/s13346-025-01890-0.
9
Nanomedicine approaches to enhance the effectiveness of meropenem: a strategy to tackle antimicrobial resistance.纳米医学方法提高美罗培南的有效性:一种应对抗菌药物耐药性的策略。
Discov Nano. 2025 Apr 1;20(1):63. doi: 10.1186/s11671-025-04244-4.
10
Liposome-Enabled Nanomaterials for Muscle Regeneration.用于肌肉再生的脂质体纳米材料
Small Methods. 2025 Feb 18:e2402154. doi: 10.1002/smtd.202402154.
二维混合电荷 MoS2 的Gram 选择性抗菌活性
J Mater Chem B. 2022 Jun 22;10(24):4588-4594. doi: 10.1039/d2tb00361a.
4
Aminophenol-Decorated Gold Nanoparticles for Curing Bacterial Infections.基于氨基酚修饰的金纳米颗粒治疗细菌性感染的研究
Nano Lett. 2022 May 11;22(9):3576-3582. doi: 10.1021/acs.nanolett.1c04968. Epub 2022 Apr 29.
5
Cefotaxime Mediated Synthesis of Gold Nanoparticles: Characterization and Antibacterial Activity.头孢噻肟介导的金纳米粒子合成:表征与抗菌活性
Polymers (Basel). 2022 Feb 16;14(4):771. doi: 10.3390/polym14040771.
6
Antibacterial and wound-healing potential of PLGA/spidroin nanoparticles: a study on earthworms as a human skin model.聚乳酸-乙醇酸共聚物/丝胶蛋白纳米粒子的抗菌和伤口愈合潜力:以蚯蚓作为人体皮肤模型的研究。
Nanomedicine (Lond). 2022 Mar;17(6):353-365. doi: 10.2217/nnm-2021-0325. Epub 2022 Feb 21.
7
2D-MoS-Based β-Lactamase Inhibitor for Combination Therapy against Drug-Resistant Bacteria.用于联合治疗耐药细菌的二维二硫化钼基β-内酰胺酶抑制剂
ACS Appl Bio Mater. 2018 Oct 15;1(4):967-974. doi: 10.1021/acsabm.8b00105. Epub 2018 Sep 14.
8
Polycationic Silver Nanoclusters Comprising Nanoreservoirs of Ag Ions with High Antimicrobial and Antibiofilm Activity.包含 AgI 纳米储库的聚阳离子银纳米簇,具有高抗菌和抗生物膜活性。
ACS Appl Mater Interfaces. 2022 Jan 12;14(1):390-403. doi: 10.1021/acsami.1c21657. Epub 2021 Dec 22.
9
Overcoming Multidrug Resistance in Bacteria Through Antibiotics Delivery in Surface-Engineered Nano-Cargos: Recent Developments for Future Nano-Antibiotics.通过表面工程化纳米载体递送抗生素克服细菌中的多重耐药性:未来纳米抗生素的最新进展
Front Bioeng Biotechnol. 2021 Jul 8;9:696514. doi: 10.3389/fbioe.2021.696514. eCollection 2021.
10
Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance.脂质体作为抗生素递送系统:一种对抗抗生素耐药性的有前景的纳米技术策略。
Molecules. 2021 Apr 2;26(7):2047. doi: 10.3390/molecules26072047.